Potential Drawbacks: Lack of robust scientific evidence: Current research doesn't strongly support significant weight loss from these injections alone
In a study involving rats with hind limb ischemia, BPC-157 treatment was found to increase the expression of VEGFR2, subsequently activating the VEGFR2-Akt-eNOS pathway
For patients who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone, GLP-1 therapy offers a potent alternative with greater potency and longer half-life compared to some other GLP-1 RA therapies
The bottleneck is cellular NAD+ availability
Muscle Preservation: Unlike traditional weight loss methods that can lead to muscle loss, AOD 9604 peptide therapy targets fat cells while preserving lean muscle mass, resulting in a more sculpted, toned physique
Possible side effects: Skin symptoms (acne as well as eczematous and urticarial drug reactions) and hypersensitivity symptoms (anaphylactic or anaphylactoid reactions) have been observed in very rare cases